论文部分内容阅读
目的:比较阿奇霉素与氯霉素用于治疗恙虫病患者的临床疗效。方法:选取2014年1—9月间收治的恙虫病患者62例的临床资料,将其分为阿奇霉素组(32例)和氯霉素组(30例);阿奇霉素组患者给予阿奇霉素治疗,氯霉素组患者给予氯霉素治疗;比较两组患者治疗后的临床疗效及症状改善情况。结果:阿奇霉素组患者临床治疗后总有效率为100.00%显著高于氯霉素组为76.67%(P<0.05);各临床症状消失时间均显著低于氯霉素组(P<0.05)。结论:采用阿奇霉素治疗恙虫病患者的临床疗效优于氯霉素的治疗,且临床疗效较显著,症状消失时间快,能快速改善患者的生活质量。
Objective: To compare the clinical efficacy of azithromycin and chloramphenicol in the treatment of tsutsugamushi disease. Methods: The clinical data of 62 patients with tsutsugamushi who were admitted from January to September in 2014 were selected and divided into azithromycin group (n = 32) and chloramphenicol group (n = 30). Patients in azithromycin group were treated with azithromycin, Patients in the prime group received chloramphenicol treatment. The clinical efficacy and symptom improvement were compared between the two groups. Results: The total effective rate of patients in azithromycin group after treatment was 100.00%, significantly higher than that in chloramphenicol group (76.67%, P <0.05). The disappearance time of each clinical symptom was significantly lower than that of chloramphenicol group (P <0.05). Conclusion: The clinical efficacy of azithromycin in the treatment of tsutsugamushi disease is better than that of chloramphenicol, and the clinical curative effect is significant, the symptoms disappear quickly, and can rapidly improve the quality of life of patients.